Cargando…
Current Opinion on Usage of L-Carnitine in End-Stage Renal Disease Patients on Peritoneal Dialysis
The advantages of peritoneal dialysis (PD) over hemodialysis (HD) are well-documented. Notwithstanding, only a small proportion of patients with end-stage renal disease (ESRD) are managed with PD. This may be related to the high glucose load that PD solutions in current use have on the patient. The...
Autores principales: | Bonomini, Mario, Di Liberato, Lorenzo, Zammit, Victor, Arduini, Arduino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803867/ https://www.ncbi.nlm.nih.gov/pubmed/31547545 http://dx.doi.org/10.3390/molecules24193449 |
Ejemplares similares
-
A New Peritoneal Dialysis Solution Containing L-Carnitine and Xylitol for Patients on Continuous Ambulatory Peritoneal Dialysis: First Clinical Experience
por: Rago, Carmela, et al.
Publicado: (2021) -
The osmo-metabolic approach: a novel and tantalizing glucose-sparing strategy in peritoneal dialysis
por: Bonomini, Mario, et al.
Publicado: (2020) -
Proteomic Research in Peritoneal Dialysis
por: Bonomini, Mario, et al.
Publicado: (2020) -
Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis
por: Masola, Valentina, et al.
Publicado: (2022) -
Mild sodium reduction in peritoneal dialysis solution improves hypertension in end stage kidney disease: a case-report study
por: Vecchi, Luigi, et al.
Publicado: (2021)